Cornelia de Lange syndrome

What is Cornelia de Lange syndrome?

Cornelia de Lange syndrome (CdLS) is a rare genetic disorder that affects multiple organ systems and causes distinctive facial features, growth delays, and varying degrees of intellectual disability. Named after Dutch pediatrician Cornelia Catharina de Lange who first described the condition in 1933, this syndrome affects both males and females of all ethnic backgrounds. CdLS occurs in approximately 1 in 10,000 to 30,000 births worldwide, making it a rare but recognizable condition among healthcare providers. The syndrome represents a spectrum of severity, with some individuals having mild features while others experience more significant medical and developmental challenges.

Key statistics

Symptoms

Key features: Synophrys (joined eyebrows), long philtrum, growth restriction, limb reduction defects, intellectual disability, distinctive facial features, hearing loss, gastroesophageal reflux, behavioral challenges.

The symptoms of CdLS form a recognizable pattern, though severity varies considerably between individuals. Distinctive facial features are often the first clue to diagnosis and include synophrys (eyebrows that meet in the middle), long eyelashes, a short upturned nose, thin downturned lips, and an elongated groove between the nose and upper lip (philtrum). The ears may be low-set and small.

Growth and development issues are universal, with most affected individuals showing prenatal and postnatal growth restriction, resulting in short stature and low birth weight. Intellectual disability ranges from mild learning difficulties to severe cognitive impairment, with most individuals falling in the mild to moderate range.

Submit Your Paper

Limb abnormalities occur in many cases, ranging from small hands and feet to more severe reduction defects including missing fingers or entire limbs. Upper limb defects are more common and severe than lower limb involvement.

Gastrointestinal problems affect the majority of individuals, including gastroesophageal reflux, feeding difficulties, and sometimes structural abnormalities of the digestive tract. Behavioral characteristics may include self-injurious behaviors, repetitive movements, and challenges with social interaction, though many individuals are described as having pleasant, sociable personalities.

Causes and risk factors

CdLS is caused by mutations in genes involved in the cohesin pathway, which is crucial for proper chromosome structure and gene regulation during development. The most commonly affected gene is NIPBL, accounting for approximately 70% of cases. Other genes include SMC1A, SMC3, HDAC8, and RAD21.

The condition follows an autosomal dominant inheritance pattern, meaning only one copy of the altered gene is needed to cause the syndrome. However, approximately 90% of cases result from de novo (new) mutations, meaning they are not inherited from parents but occur spontaneously during early development.

Risk factors are limited since most cases arise from spontaneous mutations. Advanced parental age may slightly increase risk, as with many genetic conditions, but CdLS can occur in children born to parents of any age. There are no known environmental risk factors.

Prevention

Since CdLS primarily results from spontaneous genetic mutations, there are no established prevention strategies. However, genetic counseling is valuable for families affected by the condition. For the rare families where CdLS is inherited, genetic testing of at-risk family members can be performed.

Prenatal diagnosis is possible through genetic testing when there is a known family history or when characteristic features are detected on prenatal ultrasound. Preimplantation genetic diagnosis may be an option for families with a known genetic mutation who are pursuing in vitro fertilization.

Carrier testing is not typically relevant since most cases are de novo mutations, but genetic counseling can help families understand recurrence risks and reproductive options.

Complications

Without appropriate management, individuals with CdLS may experience various complications affecting multiple organ systems. Gastrointestinal complications can include severe gastroesophageal reflux leading to esophagitis, feeding difficulties resulting in failure to thrive, and in some cases, life-threatening aspiration.

Respiratory problems may arise from structural abnormalities or severe reflux, potentially leading to recurrent pneumonia or breathing difficulties. Cardiac defects occur in some individuals and may require surgical intervention if left untreated.

Behavioral complications can significantly impact quality of life, including self-injurious behaviors that may require protective measures and specialized behavioral interventions. Sensory impairments, particularly hearing loss, can further complicate communication and learning if not addressed early.

Orthopedic complications may develop, including scoliosis and joint problems related to limb malformations.

Diagnosis

Diagnosis of CdLS relies on clinical recognition of characteristic features combined with genetic testing. The diagnostic journey often begins with healthcare providers recognizing the distinctive facial features, particularly the synophrys and characteristic facial structure.

Clinical evaluation includes detailed physical examination, growth measurements, developmental assessment, and medical history. Healthcare providers use established clinical criteria that consider facial features, limb abnormalities, growth patterns, and developmental delays.

Genetic testing provides definitive diagnosis and typically involves sequencing of the NIPBL gene first, followed by testing of other CdLS-associated genes (SMC1A, SMC3, HDAC8, RAD21) if initial testing is negative.

Additional evaluations may include echocardiogram to assess for heart defects, hearing assessment, ophthalmologic examination, and imaging studies of the limbs and spine. Gastrointestinal evaluation may include upper GI series or pH probe studies to assess reflux.

The diagnostic process can be lengthy, with many families reporting multiple medical consultations before receiving a definitive diagnosis.

Treatment

Treatment for CdLS is comprehensive and multidisciplinary, focusing on managing specific symptoms and supporting development. Gastrointestinal management often includes medications such as omeprazole or other proton pump inhibitors for reflux, along with nutritional support and sometimes feeding therapy.

Growth hormone therapy may be considered for severe growth restriction, though response varies. Surgical interventions might be necessary for severe limb malformations, cardiac defects, or gastrointestinal problems.

Developmental support includes early intervention services, physical therapy, occupational therapy, and speech therapy. Educational support and individualized education programs are crucial for optimizing learning potential.

Behavioral interventions may include environmental modifications, behavioral therapy, and in some cases, medications such as risperidone for severe behavioral challenges, though these require careful monitoring.

Hearing aids or other assistive devices may be needed for sensory impairments.

Prognosis

The prognosis for individuals with CdLS varies significantly based on the severity of features and associated medical complications. Life expectancy can be normal or near-normal for those with milder forms, while individuals with severe complications may have reduced life expectancy.

With appropriate medical management and supportive care, many individuals with CdLS can lead fulfilling lives. Early intervention and comprehensive care significantly improve outcomes for development, behavior, and quality of life.

The degree of intellectual disability is the strongest predictor of long-term independence, with some individuals able to live semi-independently while others require lifelong care and supervision.

Quality of life

Individuals with CdLS can achieve good quality of life with appropriate support and accommodations. Daily routines often require modifications for feeding difficulties, with many benefiting from specialized diets or feeding techniques. Regular exercise and physical activity should be encouraged within individual limitations.

Sleep disturbances are common and may require behavioral interventions or environmental modifications. Mental health support is important, as individuals may experience anxiety or depression, particularly as they become aware of their differences.

Educational and vocational opportunities should be tailored to individual abilities, with many individuals capable of meaningful participation in community activities and some form of employment or structured day programs.

Pregnancy and fertility

Fertility in individuals with CdLS varies depending on the severity of associated features and any genital abnormalities. Women with CdLS who become pregnant require specialized obstetric care due to potential complications related to their underlying condition.

Genetic counseling is essential for affected individuals considering pregnancy, as CdLS follows an autosomal dominant pattern with a 50% chance of transmission to offspring. Prenatal testing options should be discussed.

Medications used to manage CdLS symptoms require review for pregnancy safety, with adjustments made as needed.

Children

Children with CdLS benefit from early identification and intervention. Pediatric care focuses on growth monitoring, developmental support, and management of feeding difficulties. Early intervention services including physical, occupational, and speech therapy are crucial.

School-age children typically require individualized education programs with accommodations for their learning differences and any physical limitations. Social skills development and peer interaction should be encouraged with appropriate support.

Regular pediatric subspecialty care including cardiology, gastroenterology, and orthopedics may be necessary based on individual features.

When to see a doctor

Urgent medical attention is needed for signs of severe gastroesophageal reflux including persistent vomiting, breathing difficulties, or failure to thrive. Respiratory distress, signs of cardiac problems, or severe behavioral episodes requiring safety intervention warrant immediate care.

Routine follow-up should be maintained with the multidisciplinary team, typically including genetics, developmental pediatrics, and relevant subspecialists. New symptoms such as changes in behavior, developmental regression, or new physical symptoms should prompt medical evaluation.

Parents should seek genetic counseling if planning additional pregnancies or if family members have questions about recurrence risks.

Regional context

Specific prevalence data for CdLS in the Caucasus region (Georgia, Armenia, Azerbaijan) and Eastern Mediterranean are not well-documented in current literature. The condition is expected to occur at similar rates across populations worldwide. Healthcare providers in these regions are encouraged to contribute case reports and epidemiological data to improve understanding of CdLS prevalence and characteristics in these populations.

Regional medical genetics services and patient support networks may vary, highlighting the importance of international collaboration and resource sharing for rare disease management.

Research and clinical trials

Current research focuses on understanding the molecular mechanisms underlying CdLS and developing targeted therapies. Studies are investigating the role of the cohesin pathway in development and exploring potential therapeutic targets.

Research areas include growth hormone therapy effectiveness, behavioral interventions, and novel approaches to managing gastrointestinal complications. Gene therapy approaches are in early experimental stages.

Clinical trials can be found through ClinicalTrials.gov using the search terms “Cornelia de Lange syndrome” or “CdLS.” Families interested in research participation should discuss options with their healthcare team and consider contacting the CdLS Foundation for information about current studies.

Frequently asked questions

Is CdLS inherited from parents?

While CdLS follows an autosomal dominant inheritance pattern, approximately 90% of cases result from new (de novo) mutations not inherited from parents. Only about 10% of cases are inherited from an affected parent.

Can individuals with CdLS have children?

Yes, many individuals with milder forms of CdLS can have children. However, genetic counseling is important as there is a 50% chance of passing the condition to offspring if the individual carries a CdLS-causing mutation.

What is the life expectancy for someone with CdLS?

Life expectancy varies significantly based on the severity of features and associated medical complications. With appropriate medical care, many individuals can have normal or near-normal life expectancy, while those with severe complications may have reduced life expectancy.

Will my child with CdLS be able to attend regular school?

Many children with CdLS can attend regular school with appropriate support and accommodations. The level of support needed depends on the degree of intellectual disability and any physical limitations. Some may benefit from specialized educational settings.

Are there treatments that can cure CdLS?

Currently, there is no cure for CdLS. Treatment focuses on managing specific symptoms and supporting development. Research is ongoing to better understand the condition and develop potential targeted therapies.

Support and resources

International organizations:
– CdLS Foundation: www.cdlsusa.org
– Orphanet: www.orpha.net
– National Organization for Rare Disorders (NORD): rarediseases.org
– European Organisation for Rare Diseases (EURORDIS): www.eurordis.org
– World Health Organization (WHO): www.who.int

Regional support groups and international CdLS organizations provide valuable resources for families, including educational materials, family conferences, and connections with other affected families.

Related conditions

Kabuki syndrome
Rubinstein-Taybi syndrome
Coffin-Siris syndrome
Brachmann-de Lange syndrome
Rett syndrome

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, relevant guidelines. Informational only; not medical advice. CC BY 4.0.

Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.